Skip to main content
Top
Published in: Trials 1/2020

01-12-2020 | Insulins | Study protocol

Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach

Authors: Sobiya Sawani, Amna Rehana Siddiqui, Syed Iqbal Azam, Khadija Humayun, Asma Ahmed, Aysha Habib, Sabahat Naz, Mayera Tufail, Romaina Iqbal

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Type 1 diabetes (T1D) has been increasing globally over the past three decades. Self-monitoring of blood glucose is a challenge in both developed as well as developing countries. Self-management guidelines include maintaining logbooks for blood glucose, physical activity, and dietary intake that affect glycated hemoglobin (HbA1c) and a multitude of life-threatening acute complications. Innovative, cost-effective interventions along with beneficial lifestyle modifications can improve home-based self-monitoring of blood glucose in T1D patients. The overall objective of this study is to evaluate the relationship between maintaining log books for blood glucose levels, reinforcement by e-messages, and/or daily step count and changes in HbA1c.

Methods/design

A randomized controlled trial will enroll participants aged 15 years and above in four groups. Each group of 30 participants will be working with a newly designed standard log book for documenting their blood glucose. The first group will be entirely on routine clinical care, the second group will be on routine care and will receive an additional e-device for recording step count (fit bit), the third group will receive routine care and daily motivational e-messages to maintain the log book, and the fourth group along with routine care will receive an e-device for measuring step count (fit bit) and e-messages about maintaining the log book. Patients will be enrolled from pediatric and endocrine clinics of a tertiary care hospital in Karachi. All groups will be followed up for a period of 6 months to evaluate outcomes. Log book data will be obtained every 3 months electronically or during a patient’s clinic visit. HbA1c as a main outcome will be measured at baseline and will be evaluated twice every 3 months. A baseline questionnaire will determine the socio-demographic, nutritional, and physical activity profile of patients. Clinical information for T1D and other co-morbidities for age of onset, duration, complications, hospitalizations, habits for managing T1D, and other lifestyle characteristics will be ascertained. Behavioral modifications for maintaining daily log books as a routine, following e-messages alone, fit bit alone, or e-messages plus using fit bit will be assessed for changes in HbA1c using a generalized estimated equation.

Discussion

The proposed interventions will help identify whether maintaining log books for blood glucose, motivational e-messages, and/or daily step count will reduce HbA1c levels.

Trial registration

ClinicalTrials.gov, NCT03864991. March 6, 2019.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Chapter 1: Epidemiology of type I diabetes. Endocrine Metab Clin North Am. 2010;39(3):481–97.CrossRef Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Chapter 1: Epidemiology of type I diabetes. Endocrine Metab Clin North Am. 2010;39(3):481–97.CrossRef
3.
go back to reference Patterson C, Guariguata L, Dahlquist G, et al. Diabetes in the young--a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014;103:161–75.PubMedCrossRef Patterson C, Guariguata L, Dahlquist G, et al. Diabetes in the young--a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014;103:161–75.PubMedCrossRef
4.
go back to reference Kesavadev J, Sadikot SM, Saboo B, Shrestha D, Jawad F, Azad K, Wijesuriya MA, Latt TS, Kalra S. Challenges in type 1 diabetes management in South East Asia: descriptive situational assessment. Indian J Endocrinol Metab. 2014;18(5):600.PubMedPubMedCentral Kesavadev J, Sadikot SM, Saboo B, Shrestha D, Jawad F, Azad K, Wijesuriya MA, Latt TS, Kalra S. Challenges in type 1 diabetes management in South East Asia: descriptive situational assessment. Indian J Endocrinol Metab. 2014;18(5):600.PubMedPubMedCentral
5.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2016: summary of revisions. Diabetes Care. 2016;39(Supplement 1):S4–5.CrossRef American Diabetes Association. Standards of medical care in diabetes—2016: summary of revisions. Diabetes Care. 2016;39(Supplement 1):S4–5.CrossRef
7.
go back to reference Klienman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemed J E Health. 2017;23(9):733–40.CrossRef Klienman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemed J E Health. 2017;23(9):733–40.CrossRef
9.
go back to reference Coughlin SS, Hatzigeorgiou C, Anglin J, Xie D, Besenyi GM, De Leo G, Stewart J, Wilkins T. Healthy lifestyle intervention for adult clinic patients with type 2 diabetes mellitus. Diabetes management (London, England). 2017;7(2):197–204. Coughlin SS, Hatzigeorgiou C, Anglin J, Xie D, Besenyi GM, De Leo G, Stewart J, Wilkins T. Healthy lifestyle intervention for adult clinic patients with type 2 diabetes mellitus. Diabetes management (London, England). 2017;7(2):197–204.
10.
go back to reference Diaz KM, Krupka DJ, Chang MJ, Peacock J, Ma Y, Goldsmith J, Schwartz JE, Davidson KW. Fitbit®: An accurate and reliable device for wireless physical activity tracking. Int J Cardiol. 2015;185:138.PubMedPubMedCentralCrossRef Diaz KM, Krupka DJ, Chang MJ, Peacock J, Ma Y, Goldsmith J, Schwartz JE, Davidson KW. Fitbit®: An accurate and reliable device for wireless physical activity tracking. Int J Cardiol. 2015;185:138.PubMedPubMedCentralCrossRef
11.
go back to reference Evenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act. 2015;12(1):159.PubMedPubMedCentralCrossRef Evenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. Int J Behav Nutr Phys Act. 2015;12(1):159.PubMedPubMedCentralCrossRef
12.
go back to reference Riaz M, Basit A, Fawwad A, Ahmedani MY, Rizvi ZA. Factors associated with non-adherence to insulin in patients with type 1 diabetes. Pakistan J Med Sci. 2014;30(2):233. Riaz M, Basit A, Fawwad A, Ahmedani MY, Rizvi ZA. Factors associated with non-adherence to insulin in patients with type 1 diabetes. Pakistan J Med Sci. 2014;30(2):233.
13.
go back to reference Lone SW, Siddiqui EU, Muhammed F, Atta I, Ibrahim MN, Raza J. Frequency, clinical characteristics and outcome of diabetic ketoacidosis in children with type-1 diabetes at a tertiary care hospital. JPMA. 2010;60(9):725–9. Lone SW, Siddiqui EU, Muhammed F, Atta I, Ibrahim MN, Raza J. Frequency, clinical characteristics and outcome of diabetic ketoacidosis in children with type-1 diabetes at a tertiary care hospital. JPMA. 2010;60(9):725–9.
14.
go back to reference Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. DPV-Wiss-Initiative. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12:11–7.PubMedCrossRef Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. DPV-Wiss-Initiative. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12:11–7.PubMedCrossRef
15.
go back to reference Kovatchev BP, Otto E, Cox D, Gondor-Fredrick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29(11):2433–8.PubMedCrossRef Kovatchev BP, Otto E, Cox D, Gondor-Fredrick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29(11):2433–8.PubMedCrossRef
16.
go back to reference Patton SR, Midyett LK, Dolan LM, Powers SW. A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data. Diabetes Technol Ther. 2012;14(3):239–43.PubMedPubMedCentralCrossRef Patton SR, Midyett LK, Dolan LM, Powers SW. A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data. Diabetes Technol Ther. 2012;14(3):239–43.PubMedPubMedCentralCrossRef
17.
go back to reference Anderzén J, Samuelsson U, Gudbjornsdottir S, Henberger L, Akesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications. 2015;30(3):533–6.PubMedCrossRef Anderzén J, Samuelsson U, Gudbjornsdottir S, Henberger L, Akesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications. 2015;30(3):533–6.PubMedCrossRef
20.
go back to reference Syed M, Khawaja FB, Saleem T, Khalid U, Rashid A, Humayun KN. Clinical profile and outcomes of paediatric patients with diabetic ketoacidosis at a tertiary care hospital in Pakistan. J Pak Med Assoc. 2011;61(11):1082.PubMed Syed M, Khawaja FB, Saleem T, Khalid U, Rashid A, Humayun KN. Clinical profile and outcomes of paediatric patients with diabetic ketoacidosis at a tertiary care hospital in Pakistan. J Pak Med Assoc. 2011;61(11):1082.PubMed
21.
go back to reference Cheraghi F, Shamsaei F, Mortazavi SZ, Moghimbeigi A. The effect of family-centered care on management of blood glucose levels in adolescents with diabetes. Int J Commun Based Nurs Midwifery. 2015;3(3):177. Cheraghi F, Shamsaei F, Mortazavi SZ, Moghimbeigi A. The effect of family-centered care on management of blood glucose levels in adolescents with diabetes. Int J Commun Based Nurs Midwifery. 2015;3(3):177.
22.
go back to reference Miyauchi M, Toyoda M, Kaneyama N, Miyatake H, Tanaka E, Kimura M, Umezono T, Fukagawa M. Exercise therapy for management of type 2 diabetes mellitus: superior efficacy of activity monitors over pedometers. J Diab Res. 2016;2016:7. https://doi.org/10.1155/2016/5043964. Miyauchi M, Toyoda M, Kaneyama N, Miyatake H, Tanaka E, Kimura M, Umezono T, Fukagawa M. Exercise therapy for management of type 2 diabetes mellitus: superior efficacy of activity monitors over pedometers. J Diab Res. 2016;2016:7. https://​doi.​org/​10.​1155/​2016/​5043964.
23.
go back to reference Vaes AW, Cheung A, Atakhorrami M, Groenen MT, Amft O, Franssen FM, Wouters EF, Spruit MA. Effect of ‘activity monitor-based’counseling on physical activity and health-related outcomes in patients with chronic diseases: a systematic review and meta-analysis. Ann Med. 2013;45(5-6):397–412.PubMedCrossRef Vaes AW, Cheung A, Atakhorrami M, Groenen MT, Amft O, Franssen FM, Wouters EF, Spruit MA. Effect of ‘activity monitor-based’counseling on physical activity and health-related outcomes in patients with chronic diseases: a systematic review and meta-analysis. Ann Med. 2013;45(5-6):397–412.PubMedCrossRef
24.
go back to reference Wang JB, Cadmus-Bertram LA, Natarajan L, White MM, Madanat H, Nichols JF, Ayala GX, Pierce JP. Wearable sensor/device (Fitbit One) and SMS text-messaging prompts to increase physical activity in overweight and obese adults: a randomized controlled trial. Telemed E Health. 2015;21(10):782–92.CrossRef Wang JB, Cadmus-Bertram LA, Natarajan L, White MM, Madanat H, Nichols JF, Ayala GX, Pierce JP. Wearable sensor/device (Fitbit One) and SMS text-messaging prompts to increase physical activity in overweight and obese adults: a randomized controlled trial. Telemed E Health. 2015;21(10):782–92.CrossRef
26.
go back to reference Dasgupta K, Rosenberg E, Daskalopoulou SS. Step monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods. Cardiovasc Diabetol. 2014;13(1):7.PubMedPubMedCentralCrossRef Dasgupta K, Rosenberg E, Daskalopoulou SS. Step monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods. Cardiovasc Diabetol. 2014;13(1):7.PubMedPubMedCentralCrossRef
28.
go back to reference Basit A, Riaz M, Fawwad A. Improved diabetes care in developing countries: The example of Pakistan. Diabetes Res Clin Pract. 2015;107(2):224–32.PubMedCrossRef Basit A, Riaz M, Fawwad A. Improved diabetes care in developing countries: The example of Pakistan. Diabetes Res Clin Pract. 2015;107(2):224–32.PubMedCrossRef
30.
go back to reference Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E. ISPAD clinical practice consensus guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes. 2018;19:155–77.PubMedCrossRef Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E. ISPAD clinical practice consensus guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes. 2018;19:155–77.PubMedCrossRef
31.
go back to reference Jones TW, ISPAD Hypoglycemia Guidelines Writing Group. Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes. Pediatric Diabetes. 2018;19(3):354–5.PubMedCrossRef Jones TW, ISPAD Hypoglycemia Guidelines Writing Group. Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes. Pediatric Diabetes. 2018;19(3):354–5.PubMedCrossRef
32.
go back to reference International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155–7.CrossRef International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155–7.CrossRef
34.
go back to reference Craig CL, Marshall AL, Sjostrom M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef Craig CL, Marshall AL, Sjostrom M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef
Metadata
Title
Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach
Authors
Sobiya Sawani
Amna Rehana Siddiqui
Syed Iqbal Azam
Khadija Humayun
Asma Ahmed
Aysha Habib
Sabahat Naz
Mayera Tufail
Romaina Iqbal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-4205-7

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue